Published in J Cancer Surviv on January 09, 2015
A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer. Oncologist (2016) 0.87
Determining cancer survivors' preferences to inform new models of follow-up care. Br J Cancer (2016) 0.75
Fractalkine (C-X3-C motif chemokine ligand 1) as a potential biomarker for depression and anxiety in colorectal cancer patients. Biomed Rep (2017) 0.75
Health status, anxiety, and depressive symptoms following complicated and uncomplicated colorectal surgeries. Int J Colorectal Dis (2015) 0.75
Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev (2012) 10.32
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res (2006) 7.09
Clinical trials in children. Lancet (2004) 3.97
Meta-analysis of non-randomized comparative studies of the short-term outcomes of laparoscopic resection for colorectal cancer. ANZ J Surg (2007) 2.44
Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis. J Clin Oncol (2005) 2.39
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood (2002) 2.30
Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care (2006) 2.27
Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care. J Clin Oncol (2007) 2.27
Parents' attitudes to children's participation in randomized controlled trials. J Pediatr (2003) 2.26
What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer (2009) 2.24
Biofeedback for fecal incontinence: short-term outcomes of 513 consecutive patients and predictors of successful treatment. Dis Colon Rectum (2007) 2.24
Systematic review of peer-support programs for people with cancer. Patient Educ Couns (2008) 2.22
Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial. J Clin Oncol (2008) 2.15
Pancreatic cancer: surgical management and outcomes after 6 years of follow-up. Med J Aust (2012) 2.12
Gene-engineered T cells for cancer therapy. Nat Rev Cancer (2013) 2.07
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res (2006) 2.05
Activation of NK cell cytotoxicity. Mol Immunol (2005) 2.03
Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr (2002) 2.01
A randomized controlled trial of a nurse-administered educational intervention for improving cancer pain management in ambulatory settings. Patient Educ Couns (2004) 1.99
When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol (2002) 1.99
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust (2007) 1.99
Improving doctors' letters. Med J Aust (2002) 1.98
Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. Hum Gene Ther (2002) 1.96
A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manage (2007) 1.92
Dual-specific T cells combine proliferation and antitumor activity. Nat Biotechnol (2002) 1.92
Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol (2004) 1.88
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol (2007) 1.74
Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening? J Clin Oncol (2007) 1.66
Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation. Surgery (2003) 1.63
Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med (2007) 1.60
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination. J Clin Oncol (2006) 1.56
Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J Immunol (2002) 1.50
Preferences for outcomes of treatment for rectal cancer: patient and clinician utilities and their application in an interactive computer-based decision aid. Dis Colon Rectum (2009) 1.49
Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey. J Oncol Pract (2008) 1.49
Provision of taped conversations with neonatologists to mothers of babies in intensive care: randomised controlled trial. BMJ (2006) 1.45
A systematic review of reasons for nonentry of eligible patients into surgical randomized controlled trials. Surgery (2006) 1.44
Exercise rehabilitation for patients with critical illness: a randomized controlled trial with 12 months of follow-up. Crit Care (2013) 1.43
Sustaining hope when communicating with terminally ill patients and their families: a systematic review. Psychooncology (2008) 1.42
Cutting edge: TRAIL deficiency accelerates hematological malignancies. J Immunol (2005) 1.40
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial. J Clin Oncol (2009) 1.40
We still have to work to break the silence. Collegian (2015) 1.40
A matter of trust--patient's views on decision-making in colorectal cancer. Health Expect (2004) 1.38
Three questions that patients can ask to improve the quality of information physicians give about treatment options: a cross-over trial. Patient Educ Couns (2011) 1.37
The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. J Cancer Surviv (2009) 1.36
Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist (2012) 1.34
Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia. Mol Ther (2013) 1.33
Desire for hastened death in patients with advanced disease and the evidence base of clinical guidelines: a systematic review. Palliat Med (2006) 1.33
Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol (2005) 1.30
Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results. Health Expect (2002) 1.30
Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy. J Clin Oncol (2011) 1.29
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy. Oncoimmunology (2013) 1.29
A psycho-educational intervention for family caregivers of patients receiving palliative care: a randomized controlled trial. J Pain Symptom Manage (2005) 1.29
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis (2013) 1.27
Survivorship issues following treatment completion--results from focus groups with Australian cancer survivors and health professionals. J Cancer Surviv (2008) 1.27
Does age really matter? Recall of information presented to newly referred patients with cancer. J Clin Oncol (2008) 1.25
A one-item question with a Likert or Visual Analog Scale adequately measured current anxiety. J Clin Epidemiol (2006) 1.24
Can a "prompt list" empower cancer patients to ask relevant questions? Cancer (2008) 1.23
Autoimmunity associated with immunotherapy of cancer. Blood (2011) 1.22
Family meetings in palliative care: Multidisciplinary clinical practice guidelines. BMC Palliat Care (2008) 1.20
What are the current barriers to effective cancer care coordination? A qualitative study. BMC Health Serv Res (2010) 1.19
Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Cancer Res (2007) 1.19
Development and pilot testing of a nurse-led posttreatment support package for bowel cancer survivors. Cancer Nurs (2011) 1.19
Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support Care Cancer (2011) 1.19
Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol (2009) 1.18
Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer (2005) 1.18
Increasing oncologists' skills in eliciting and responding to emotional cues: evaluation of a communication skills training program. Psychooncology (2008) 1.18
Meeting the supportive needs of family caregivers in palliative care: challenges for health professionals. J Palliat Med (2004) 1.17
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. Cancer Immun (2004) 1.15
Lung cancer: challenges and solutions for supportive care intervention research. Palliat Support Care (2008) 1.15
Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review. J Pediatr Hematol Oncol (2006) 1.15
Women's preferences for and views on decision-making for diagnostic tests. Soc Sci Med (2004) 1.15
Facilitating patient-centered cancer communication: a road map. Patient Educ Couns (2009) 1.15
Towards better communication in cancer care: a framework for developing evidence-based interventions. Patient Educ Couns (2004) 1.13
Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psychooncology (2007) 1.13
Gene modification strategies to induce tumor immunity. Immunity (2005) 1.12
To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option. J Clin Oncol (2009) 1.12
Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genet Med (2009) 1.10
Predictors of breast cancer screening behavior in women with a strong family history of the disease. Breast Cancer Res Treat (2010) 1.10
Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns (2009) 1.10
When and how to initiate discussion about prognosis and end-of-life issues with terminally ill patients. J Pain Symptom Manage (2005) 1.10
Appropriate, timely referral to palliative care services: a name change will not help. J Clin Oncol (2013) 1.09
Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. Lancet Oncol (2011) 1.09
Fatigue and sleep disturbance following traumatic brain injury--their nature, causes, and potential treatments. J Head Trauma Rehabil (2012) 1.08
Discrepant perceptions about end-of-life communication: a systematic review. J Pain Symptom Manage (2007) 1.08
Improving survivorship care. J Clin Oncol (2012) 1.08